Exchange: NASDAQ·Updated 09:48 AM EDT
MDXG logo

MDXGMimedx Group Inc

$4.27
$0.05
(1.16%)
Today
EarningsJul 29
Mkt Cap$643.45M
Vol9,645.00
News
all
press releases
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts PR Newswire TAMPA, Fla., June 2, 2026 Issued on behalf of Conexeu Sciences Inc.A newly listed...
PR Newswire
More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx...
PR Newswire
Is the Options Market Predicting a Spike in MiMedx Group Stock?
Investors need to pay close attention to MDXG stock based on the movements in the options market lately.
Zacks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx...
PR Newswire
MiMedx Group (NASDAQ:MDXG) Stock Rating Lowered by Wall Street Zen
Wall Street Zen lowered MiMedx Group from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat
MiMedx Group (NASDAQ:MDXG) Stock Price Up 7% - Still a Buy?
MiMedx Group (NASDAQ:MDXG) Shares Up 7% - Should You Buy...
MarketBeat
MiMedx Group (NASDAQ:MDXG) Price Target Lowered to $6.00 at Citizens Jmp
Citizens Jmp dropped their price objective on MiMedx Group from $7.00 to $6.00 and set a "market outperform" rating on the stock in a report on Thursday...
MarketBeat
MiMedx Group (NASDAQ:MDXG) Issues Earnings Results
MiMedx Group (NASDAQ:MDXG - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by...
MarketBeat
MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates
MiMedx (MDXG) delivered earnings and revenue surprises of +28.57% and +3.49%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
MiMedx Group Q1 Earnings Call Highlights
MiMedx Group (NASDAQ:MDXG) reported first-quarter 2026 results showing sharp divergence between its wound care and surgical businesses as the company worked through what executives described as significant disruption tied to a new Medicare reimbursement framework for skin substitutes. On the compan...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.